Stock Events

Fusen Pharmaceutical Company Limited 

HK$1.25
0
+HK$0+0% Today

Statistics

Day High
1.25
Day Low
1.25
52W High
1.6
52W Low
1.15
Volume
1,000
Avg. Volume
184,033
Mkt Cap
993.56M
P/E Ratio
65.5
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

29AugExpected
Q1 2018
Q2 2018
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1652.HK. It's not an investment recommendation.

About

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Show more...
CEO
Mr. Changcheng Cao
Employees
1143
Country
Hong Kong
ISIN
KYG370981030

Listings